Response Genetics, Inc. Renews Agreement With Taiho Pharmaceutical to Provide Molecular Analyses for Cancer

Published: Jul 17, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LOS ANGELES, July 17, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's response to cancer therapy, today announced that it has extended its agreement with Taiho Pharmaceutical Co., Ltd. to provide testing and analyses services for specified molecular markers used in research, diagnosis and the therapeutic treatment of cancer.

Help employers find you! Check out all the jobs and post your resume.

Back to news